SCHEMBL2594210

SCHEMBL2594210

CC(=CCC(O)C(C)O)C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CD81 P60033 1/20 0.33
GRIK1 P39086 1/20 0.32
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2594207 1.00 CD81 (0.33) CD81GRIK1TP53
SCHEMBL27793 0.82 CD81 (0.35) CD81GRIK1TP53
SCHEMBL150232 0.82 CD81 (0.35) CD81GRIK1TP53
SCHEMBL3273630 0.81 PDE4A (0.34) CD81
SCHEMBL8634500 0.81 PDE4A (0.34) CD81
Acetone SCHEMBL29420371 0.80 CD81 (0.34) CD81GRIK1TP53
SCHEMBL23252 0.79 GRIK1 (0.47) CD81GRIK1
SCHEMBL23250 0.79 GRIK1 (0.47) CD81GRIK1
SCHEMBL236096 0.79 GRIK1 (0.35) CD81GRIK1
SCHEMBL9339953 0.79 CD81 (0.36) CD81GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10072113-B2 Composition, curable composition, production method therefor, and cured product SHOWA DENKO K.K. (JP) 2018-09-11 US disclosed
US-20160168295-A1 COMPOSITION, CURABLE COMPOSITION, PRODUCTION METHOD THEREFOR, AND CURED PRODUCT SHOWA DENKO K.K. (JP) 2016-06-16 US disclosed
US-20150086777-A1 LAMINATED FILM AND METHOD FOR PRODUCING SAME TORAY INDUSTRIES, INC. (JP) 2015-03-26 US disclosed
US-8821843-B2 Rheology modifying and setting polymer, composition thereof and method for making it BASF SE (DE) 2014-09-02 US disclosed
EP-2623575-A1 ADHESIVE COMPOSITION, COATING COMPOSITION, PRIMER USING SAME, INKJET INK, ADHESIVE METHOD, AND LAMINATE Riken Technos Corp. (JP) 2013-08-07 EP disclosed
EP-2563828-B1 RHEOLOGY MODIFYING AND SETTING POLYMER, COMPOSITION THEREOF AND METHOD FOR MAKING IT BASF SE (DE) 2013-07-24 EP disclosed
US-20130177719-A1 ADHESIVE COMPOSITION, COATING COMPOSITION, AND PRIMER, INKJET INK, ADHESION METHOD AND LAMINATE USING THE SAME COMPOSITION BASF SE (DE) 2013-07-11 US disclosed
US-20130129658-A1 Rheology Modifying and Setting Polymer, Composition thereof and Method for Making It BASF SE (DE) 2013-05-23 US disclosed
EP-2563828-A1 RHEOLOGY MODIFYING AND SETTING POLYMER, COMPOSITION THEREOF AND METHOD FOR MAKING IT BASF SE (DE) 2013-03-06 EP disclosed
US-8232328-B2 Color filter ink, color filter, image display device, and electronic device SEIKO EPSON CORPORATION (JP) 2012-07-31 US disclosed
US-7527876-B2 Chromium free; heat discoloration resistance; corrosion resistance; blackening resistance JFE STEEL CORPORATION (JP) 2009-05-05 US disclosed
US-20090073356-A1 COLOR FILTER INK, COLOR FILTER, IMAGE DISPLAY DEVICE, AND ELECTRONIC DEVICE SEIKO EPSON CORPORATION (JP) 2009-03-19 US disclosed
US-20080063896-A1 Surface-treated steel sheet JFE STEEL CORPORATION (JP) 2008-03-13 US disclosed
US-20070270733-A1 Iontophoresis Device TOKUYAMA CORPORATION (JP) 2007-11-22 US disclosed
US-20070170067-A1 Electroplating solution composition for organic polymer-zinc alloy composite plating and plated metal material using such composition KANSAI PAINT CO., LTD. 2007-07-26 US disclosed
EP-1767243-A1 IONTOPHORESIS APPARATUS Tokuyama Corporation (JP) 2007-03-28 EP disclosed
US-6994745-B2 Pigment dispersing resin KANSAI PAINT CO., LTD. (JP) 2006-02-07 US disclosed
US-20050205165-A1 Coating composition for forming titanium oxide film, process for forming titanium oxide film and metal substrate coated with titanium oxide film KANSAIPAINT CO., LTD. (JP) 2005-09-22 US disclosed
US-20050112413-A1 Gas barrier film KANSAI PAINT CO., LTD. (JP) 2005-05-26 US disclosed
US-20030179269-A1 Ink-jet printing KANSAI PAINT CO., LTD. (JP) 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072113-B2 Composition, curable composition, production method therefor, and cured product NOTUM, FAR1, THEM6 CD81 3271/4885GRIK1 2319/4885TP53 3121/4885
US-20130129658-A1 Rheology Modifying and Setting Polymer, Composition thereof and Method for Making It MMAB, ASS1, REV1 CD81 4377/4885GRIK1 1778/4885TP53 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.